GW501516
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GW501516, covering 2017-05-30 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol [Phase 2]